02 Jun 2024
// BUSINESSWIRE
20 Dec 2022
// PRESS RELEASE
https://www.gilead.com/news-and-press/press-room/press-releases/2022/12/anti-tigit-domvanalimab-containing-study-arms-improve-progression-free-survival-compared-to-anti-pd1-alone-in-phase-2-non-small-cell-lung-cancer-study
LOOKING FOR A SUPPLIER?